Five Ovation-Supported Research Abstracts Presented at ASRM 2023
Ovation Fertility’s nationwide team of leading IVF scientists was honored with three poster and two oral acceptances at the ASRM 2023 Scientific Congress and Expo.
Matthew “Tex” VerMilyea, PhD, HCLD/CC, Vice President of Scientific Advancement, Ovation Fertility
Nashville, Oct. 18, 2023 (GLOBE NEWSWIRE) — Ovation® Fertility teams presented three poster and two oral presentations at the 2023 ASRM Scientific Congress & Expo, which takes place in New Orleans, Louisiana, October 14-18, 2023.
“ASRM is an event that we look forward to and work toward every year because it provides us so many opportunities to learn and share with other experts in reproductive medicine,” says Matthew “Tex” VerMilyea, Ph.D., HCLD/CC, Ovation’s vice president of scientific advancement. “We are very excited to have been invited to showcase many of our latest research findings, produced in collaboration with our physician partners and key suppliers of advanced reproductive technologies, such as artificial intelligence.”
This year’s Ovation-supported presentations covered advances in intracytoplasmic sperm injection (ICSI), embryo vitrification, and the use of AI in embryo selection.
O-1 – CLINICAL EVALUATION OF A MACHINE LEARNING MODEL FOR EMBRYO SELECTION: A DOUBLE-BLINDED RANDOMIZED COMPARATIVE READER STUDY
Oleksii O. Barash, PhD1, Fernanda Murillo Armijo, BS, MS2, Justina Hyunjii Cho, MA, MS3, Vaishali Suraj, MS4, Kevin E Loewke, PhD4, Jason E Swain, PhD5, Kathleen A Miller, DHSc6, and Matthew VerMilyea, HCLD, PhD7
(1)Reproductive Science Center of the San Francisco Bay Area, San Ramon, CA, (2)Alife Health, Inc., Cambridge, MA, (3)Alife Health, Inc., (4)Alife Health, Inc., San Francisco, CA, (5)CCRM Fertility, Lone Tree, CO, (6)IVF Florida Reproductive Associates, Margate, FL, (7)Ovation Fertility, Austin, TX
O-179 – DEVELOPMENT OF A NON-INVASIVE ARTIFICIAL INTELLIGENCE ALGORITHM FOR IDENTIFICATION OF EUPLOID EMBRYOS WITH HIGH MORPHOLOGICAL QUALITY DURING IVF
Matthew VerMilyea, HCLD, PhD1, Sonya M Diakiw, PhD2, Jonathan MM Hall, BSC, PhD3, Carla Giménez, PhD Student4, Laura Conversa Martínez, PhD Student5, Marcos Meseguer, PhD4, Kathleen A Miller, DHSc6, Kathleen Devine, MD7, Tuc Van Nguyen, PhD8, Don Perugini, PhD8 and Michelle Perugini, PhD9
(1)Ovation Fertility, San Antonio, TX, (2)Life Whisperer Diagnostics Inc (a subsidiary of Presagen), San Francisco, CA, (3)Australian Research Council Centre of Excellence for Nanoscale BioPhotonics, Adelaide, SA, Australia, (4)IVIRMA Global, Valencia, Spain, (5)IVI Foundation – La Fe Health Research Institute, Valencia, Comunidad Valenciana, Spain, (6)IVF Florida Reproductive Associates, Margate, FL, (7)Shady Grove Fertility, Rockville, MD, (8)Presagen and Life Whisperer, Adelaide, SA, Australia, (9)San Francisco Bay Area, Los Gatos, CA
P-9 – AUTOMATED MORPHOLOGY GRADING OF BLASTOCYST STAGE EMBRYOS FROM A SINGLE IMAGE USING DEEP LEARNING
Zeyu Chang, MS1, Justina Hyunjii Cho, MA, MS2, Denny Sakkas, PhD3, Kathleen A Miller, DHSc4, Matthew VerMilyea, HCLD, PhD5, Oleksii O. Barash, PhD6, and Kevin E Loewke, PhD1
(1)Alife Health, Inc., San Francisco, CA, (2)Alife Health, Inc., (3)Boston IVF, Waltham, MA, (4)IVF Florida Reproductive Associates, Margate, FL, (5)Ovation Fertility, Austin, TX, (6) Reproductive Science Center of the San Francisco Bay Area, San Ramon, CA
P-89 – EFFECT OF REDUCING THE VITRIFICATION AND WARMING TIMES ON BLASTOCYST SURVIVAL AND PREGNANCY RATES
Khalied Kaskar, HCLD, PhD1, Kristin R. Sieren, MS1, Vonda M Brabner, BS, MSC1, Brogan R Huneke, BS1, Lindsey VerMilyea, MS2, Matthew VerMilyea, HCLD, PhD1, and Kaylen Silverberg, MD3
(1)Ovation Fertility, Austin, TX, (2)Fujifilm Irvine Scientific, Santa Ana, CA, (3)Texas Fertility Center, Austin, TX
P-101 – FEASIBILITY OF INJECTING IMMATURE M1 OOCYTES IN TERMS OF BLASTOCYST AND EUPLOIDY RATES
Haley N Teets, BS1, Khalied Kaskar, HCLD, PhD1, Matthew VerMilyea, HCLD, PhD1 and Kaylen Silverberg, MD2
(1)Ovation Fertility, Austin, TX, (2)Texas Fertility Center, Austin, TX
Ovation research presented at ASRM 2023 is available at www.OvationFertility.com/Research.
About Ovation Fertility
Ovation® Fertility, a US Fertility company, is a national network of laboratories providing leading-edge treatment through leading reproductive experts. Ovation’s IVF and genetics laboratories, along with affiliated physician practices, work collaboratively to raise the bar for IVF treatment, with state-of-the-art, evidence-based fertility services that give hopeful parents the best chance for a successful pregnancy. Physicians partner with Ovation to offer their patients preimplantation genetic testing, frozen donor services, surrogacy services, and secure storage for frozen biomaterials. https://www.ovationfertility.com
About US Fertility
US Fertility, the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, along with Ovation Fertility, a national network of premier IVF laboratories, are united under a shared mission to deliver the joy of parenthood through advanced reproductive medicine and innovative science. To date, US Fertility and Ovation Fertility practices have helped more than 225,000 individuals and couples build their families using assisted reproductive technology. US Fertility supports over 200 physicians by leveraging collective expertise, driving innovation, and by providing advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care. Together with a growing suite of life science services, US Fertility is expanding access to the highest quality reproductive health care across over 100 clinic locations and 32 IVF laboratories. Visit www.USFertility.com for more information.
CONTACT: Amy Hall Ovation Fertility 214.893.8214 [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.